[Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy].

doi:10.1556/MOnkol.53.2009.4.2

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy].

Magyar onkologia - 1 Dec 2009

Kulka Janina, Tokés Anna-Mária, Tóth Adrienn Ildikó, Szász Attila Marcell, Farkas Andrea, Borka Katalin, Járay Balázs, Székely Eszter, Istók Roland, Lotz Gábor, Madaras Lilla, Korompay Anna, Harsányi László, László Zsolt, Rusz Zoltán, Molnár Béla Akos, Molnár István Arthur, Kenessey István, Szentmártoni Gyöngyvér, Székely Borbála, Dank Magdolna

Abstract excerpt

The purpose of the study was to identify breast cancer subtypes by immunohistochemistry likely to respond to neoadjuvant chemotherapy and to analyze the used chemotherapy regimen and the range of response rates. Analysis of a collected database was performed. Ninety-two patients were identified in our files who received neoadjuvant chemotherapy between 1998 and 2009. We used immunohistochemical profiles (ER, PgR,...

Topics

Anthracyclines
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Breast Neoplasms
Female
Humans
Immunohistochemistry
Ki-67 Antigen
Neoadjuvant Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Phenotype

Predictive Value of Tests

Receptor, ErbB-2

Receptors, Estrogen

Receptors, Progesterone

Taxoids

Treatment Outcome

Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 20071305
DOI: 10.1556/MOnkol.53.2009.4.2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.